New Roche Award for Antibody-based Cancer Therapy Research
News May 15, 2013
In a newly created award, pRED`s Discovery Oncology unit of Roche in Penzberg, Germany invites European researchers to submit abstracts which describe their scientific work in the field of tumor-selective membrane targets for antibody-based cancer therapy. The award aims to honor and support outstanding research in the academia field and will further strengthen Roche´s interaction with the international research community.
“Roche has a long tradition of successful exchange with many research institutions all over the world,” states Klaus Bosslet, Head of Discovery Oncology Penzberg. “With the new award we emphasize our commitment to intensifying collaboration with academia and continuing support of innovative cancer research.”
The abstracts will be reviewed by a jury consisting of scientific experts from academia and Roche. Qualified applicants include graduate students and postdoctoral fellows from the research labs based in Europe. The authors of the ten best contributions will be invited to the Roche Penzberg campus near Munich, for oral presentation, poster discussion and award ceremony in November 2013. The three winners will be selected at the symposium and receive an award of 4,000 €, 2,000 €, and 1,000 €, respectively.
For submission and related information, please visit www.roche.de/abstract. The deadline for abstract submission is August 15, 2013.
SYGNIS AG Announces Completion of Relocation of its Innova Biosciences UnitNews
Move forms part of integration into SYGNIS Group.READ MORE
Mechanism Behind Inflammatory Response to Cytoplasmic DNA IdentifiedNews
A team led by LMU‘s Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in mice.READ MORE
Pathway in Neurons may Contribute to Neurodegenerative DiseaseNews
Pathway has received attention as potential drug target.READ MORE